1Department of Neurosurgery and.
2Center for Functional Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Neurosurg Focus. 2020 Dec;49(6):E11. doi: 10.3171/2020.9.FOCUS20666.
The ongoing coronavirus disease 2019 (COVID-19) pandemic has considerably affected the delivery of postoperative care to patients who have undergone deep brain stimulation (DBS) surgery. DBS teleprogramming technology was developed and deployed in China before the COVID-19 outbreak. In this report, the authors share their experiences with telemedical DBS treatment of patients with psychiatric disorders during the COVID-19 outbreak.
Four patients (2 with obsessive-compulsive disorder, 1 with major depressive disorder, and 1 with anorexia nervosa) underwent DBS surgery at Ruijin Hospital and received continuous postoperative DBS telemedicine case management from January 2020 to July 2020. DBS teleprogramming, individualized psychological support, and medical consultations were provided via the authors' DBS telemedicine platform, which also incorporated a synchronous real-time video communication system.
Forty-five DBS telemedicine sessions were conducted; there was no unexpected loss of network connection during the sessions. Of these, 28 sessions involved DBS teleprogramming. Adjustments were made to the stimulation voltage, frequency, pulse width, and contact site in 21, 12, 9, and 9 sessions, respectively. Psychological support and troubleshooting were provided during the remaining telemedicine sessions. Modest to substantial clinical improvements after DBS surgery were observed in some but not all patients, whereas stimulation-related side effects were reported by 2 patients and included reversible sleep and mood problems, headache, and a sensation of heat.
DBS telemedicine seems to offer a feasible, safe, and efficient strategy for maintaining the delivery of medical care to psychiatric patients during the COVID-19 outbreak. The authors propose that implementation of a comprehensive DBS telemedicine system, which combines DBS teleprogramming with psychological counseling, medical consultations, and medication prescriptions and delivery, could be an efficient and effective approach to manage the mental health and quality of life of patients with psychiatric disorders during future local or global public health crises.
持续的 2019 年冠状病毒病(COVID-19)大流行极大地影响了接受深部脑刺激(DBS)手术的患者的术后护理。在中国 COVID-19 爆发之前,DBS 远程程控技术已经开发并部署。在本报告中,作者分享了在 COVID-19 爆发期间使用远程医疗 DBS 治疗精神障碍患者的经验。
2020 年 1 月至 7 月,瑞金医院对 4 例患者(2 例强迫症,1 例重度抑郁症,1 例神经性厌食症)进行了 DBS 手术,并通过作者的 DBS 远程医疗平台对他们进行了连续的术后 DBS 远程医疗病例管理。该平台还采用了同步实时视频通信系统,为他们提供 DBS 远程程控、个性化心理支持和医疗咨询。
共进行了 45 次 DBS 远程医疗会议,会议期间没有出现意外的网络连接中断。其中,有 28 次涉及 DBS 远程程控。分别对 21、12、9 和 9 次会议中的刺激电压、频率、脉冲宽度和接触部位进行了调整。在其余的远程医疗会议中提供了心理支持和故障排除。在一些患者中观察到 DBS 手术后有适度到显著的临床改善,但并非所有患者均如此,而 2 名患者报告了与刺激相关的副作用,包括可逆的睡眠和情绪问题、头痛和发热感。
DBS 远程医疗似乎为在 COVID-19 大流行期间为精神科患者提供医疗服务提供了一种可行、安全和有效的策略。作者建议,实施综合的 DBS 远程医疗系统,将 DBS 远程程控与心理咨询、医疗咨询、药物处方和配送相结合,可能是管理精神障碍患者心理健康和生活质量的有效方法,无论是在未来的地方或全球公共卫生危机中。